Monica Ahrens
Papers
1
Total Citations
3
H-Index
1
About
Monica Ahrens is a clinical researcher whose work focuses on optimizing multimodal treatment strategies for head and neck cancers, particularly human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinomas (OPSCCs). Her major contributions center on understanding how the timing of surgery and adjuvant radiation therapy (RT) affects patient outcomes. In her highly cited 2024 multi-institutional cohort study, she investigated the association between the time from surgery to the start of RT (TSRT) and treatment efficacy in HPV+ OPSCC. This work directly addresses National Comprehensive Cancer Network (NCCN) guidelines, which recommend a TSRT within six weeks to avoid compromising outcomes. By analyzing real-world data across multiple institutions, Ahrens provided critical evidence that helps refine postoperative care protocols, potentially sparing patients from unnecessary delays that could reduce the effectiveness of adjuvant therapy. Her research has garnered attention from both surgical and radiation oncology communities, with her most cited paper accumulating three citations in its first year—a strong start for a recent publication. Ahrens’ work exemplifies the growing emphasis on precision timing in cancer care, offering actionable insights for clinicians managing HPV+ head and neck cancer patients.
Research Focus
Key Achievements
Top Papers
- 1